Explore the latest in gastroduodenal ulcer, including endoscopic diagnosis, management, and advances in H pylori treatment algorithms.
This JAMA Patient Page describes the types of nonprescription heartburn medications: antacids, histamine 2 blockers, and proton pump inhibitors.
This cohort study identifies the clinical outcomes of patients with hormone receptor–positive and ERBB2-negative advanced or metastatic breast cancer who concomitantly use proton pump inhibitors and palbociclib.
This cohort study analyzes the association of proton pump inhibitor use with treatment outcomes among patients in Japan with non−small cell lung cancer receiving immune checkpoint inhibitor therapy with or without chemotherapy.
This cohort study examines whether the risk of low birth weight is associated with prenatal exposure to proton pump inhibitors.
This cohort study examines whether prenatal or infant exposure to acid-suppressive medications is associated with increased risk of allergic diseases in children.
This case-control study assesses the association between the use of proton pump inhibitors and the risk of acquiring drug-resistant Enterobacterales and examines interactions with possible microbiome-altering agents among adult hospitalized patients.
This cohort study uses data from a nationwide database in South Korea to examine the association between exposure to proton pump inhibitors in the first trimester of pregnancy and the risk of congenital malformations among live-born infants.
This descriptive case series investigates the potential association between the use of proton pump inhibitors and drug-induced lupus erythematosus in cases reported in 2 large pharmacovigilance databases.
This cohort study examines whether proton pump inhibitor use during pregnancy is associated with the rate of preeclampsia.
This cohort study examines plasma metabolomics in individuals with gastric lesions and gastric cancer to identify metabolite signatures that might serve as biomarkers for risk of progression of the lesions to cancer.
This cross-sectional study evaluates the prevalence of proton pump inhibitor use among patients with cancer at 4 French comprehensive cancer centers.
This cohort study investigates the association between initiating use of proton pump inhibitors and the risk of asthma in children.
This case report describes a man in his 80s who had a rash composed of erythematous polycyclic plaques with peripheral scale and central hyperpigmentation.
This study of a Swedish national registry cohort assesses the association between proton pump inhibitor use and risk of fracture in children.
This cluster randomized trial compares the effects of proton pump inhibitors (PPIs) vs histamine-2 receptor blockers (H2RBs) on 90-day mortality among patients requiring invasive mechanical ventilation within 24 hours of admission to the intensive care unit (ICU).
Customize your JAMA Network experience by selecting one or more topics from the list below.